Therapeutic Goods (Adverse Events Following Immunisation) (Information) Specification 2021 (Cth)

Therapeutic Goods (Adverse Events Following Immunisation) (Information) Specification 2021

I, Jane Cook, as delegate of the Minister for Health and Aged Care, make the following specification.

Dated 12 March 2021

Dr Jane Cook First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health

Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Release of therapeutic goods information Schedule 1—Therapeutic goods information

1 Name This instrument is the Therapeutic Goods (Adverse Events Following Immunisation) (Information) Specification 2021.

2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument The day after this instrument is registered.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority This instrument is made under subsection 61(5AB) of the Therapeutic Goods Act 1989.

4 Definitions

Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following: (a) health practitioner; (b) Secretary; (c) State; and (d) therapeutic goods.